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ABSTRACT 
 
Intrauterine growth restriction (IUGR) increases the incidence of perinatal complications, and although 
several placental transport functions have been shown to be altered in pregnancies complicated by 
IUGR, the mechanism behind it is not well understood. This study investigated factors in maternal and 
cord blood plasma from normal and IUGR complicated pregnancies associated with newborns' body 
weight. At the time of caesarean section, twenty-four women with IUGR pregnancies were compared to a 
group of thirty normal controls with appropriate gestation age (AGA) fetuses that were studied at 
caesarean, which took place 5 weeks earlier than IUGRs and also to a group of twenty-five nondelivered 
gestational age-matched control pregnant women (AGA-35 wks). Maternal plasma retinol, γ- and α-
tocopherol, non-esterified fatty acids (NEFA), palmitic-, palmitoleic-, γ-linolenic- and arachidonic-acid were 
higher in women with IUGR pregnancies than in AGA-35 wks controls, whereas stearic- and α-linolenic-
acid were lower. Smaller differences were found when comparing these variables for IUGR and AGA 
women. However, umbilical vein plasma γ-tocopherol, cholesterol, triacylglycerols and NEFA were higher 
in the IUGR group than in AGA, whereas arachidonic acid was lower. Maternal plasma retinol and NEFA 
were the only variables negatively correlated with birth weight when multiple linear regressions were 
analyzed. In conclusion, the increased circulating retinol and NEFA in maternal plasma are negatively 
associated with birth and placental weights, which may reflect an impaired placental transfer in IUGR 
pregnancies. Since retinoids have been involved in the control of gene transcription, it is proposed that a 
decreased placental transfer of retinol could underlie the metabolic dysfunction of IUGR pregnancies. 
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INTRODUCTION 
The human fetus is dependent on adequate placental transport of fatty acids from the maternal 
circulation, in addition to many other nutrients, for normal development and growth. Lipids are 
essential components of cell membranes, function as important energy sources and, are also 
precursors to cellular signaling molecules. In particular, the essential fatty acids (EFA), linoleic acid 
(LA, C18:2n-6) and α-linolenic acid (ALA, C18:3n-3) and their long-chain polyunsaturated fatty acid 
(LCPUFA) derivatives, play a critical role in fetal development [1]. Thus, although LCPUFA are 
ubiquitous components in every mammalian cell, a significant accretion of them has been observed in 
fetal brain and retina during the last trimester of pregnancy [2]. LCPUFA can be endogenously 
synthesized from precursor EFAs in a process that involves delta-6 and delta-5 desaturases, 
constituting the n-6 and n-3 PUFA metabolic pathways respectively [3]. This process is thought to 
occur at an adequate rate in healthy human adults but not in fetuses. Moreover, placenta lacks the 
desaturase enzymes to convert EFAs [4], and therefore LCPUFAs should derive predominantly from 
the mother via placental transfer during fetal life. 
Intrauterine growth restriction (IUGR) is characterized by the failure of the fetus to reach its growth 
potential. In the short term, IUGR increases the incidence of perinatal complications including neonatal 
death, impaired neurological development and respiratory distress syndrome [5]. Several placental 
transport functions are altered in pregnancies complicated by IUGR [6, 7], and consequently this 
dysfunction can markedly affect normal fetal growth and development. However, the mechanism 
behind this is not well understood. 
There are studies that suggest micronutrients have direct effects or may be markers for other 
underlying determinants of pregnancy outcomes [8]. It is known that vitamin A (retinol) is a lipid-
soluble micronutrient required for normal mammalian reproduction and embryonic [9] and fetal 
development [10-12]. Moreover, through interactions with nuclear receptors, retinoic acid, the 
biologically active form of vitamin A, can modulate gene transcription rates involved in the regulation of 
cell proliferation and differentiation [13]. In plasma, vitamin A is transported in combination with carrier 
molecules such as the retinol binding protein (RBP)-transthyterin complex [14]. Placental uptake of 
retinol involves the specific interaction of serum RBP with a plasma membrane receptor at the 
extracellular surface [15-17], followed by ligand transfer to the cytoplasmatic cellular retinol binding 
protein (CRBP) in a membrane-dependent manner [15]. Thus the fetus acquires vitamin A from 
maternal circulation. Experiments in vitro have shown that the fatty acid status of cells are 
determinants of retinol uptake [18], not only because they control bilayer fluidity and thereby influence 
membrane transport and function [19, 20], but also because they induce CRBP expression [21]. 
In order to attain a better understanding of the factors that may be influencing placental function and 
consequent fetal growth in IUGR complicated pregnancies, this study analyzes the circulating levels of 
lipids and lipophilic vitamins during normal and IUGR pregnancies, in both maternal and umbilical vein 
plasma.  
 
MATERIALS AND METHODS 
Subjects 
In this retrospective case-control study, samples were obtained from pregnant women admitted to the 
Obstetrics and Gynecology Unit of the San Paolo Hospital, Milan and to the Obstetrics and 
Gynecology Unit of the Clinica Mangiagalli of Milan University, during a four year period (October 
2000-June 2005). The University of Milan Ethical Board approved the study protocol. Informed 
consent was obtained from all the subjects. 
Women with maternal diseases known to affect fetal growth, such as autoimmune and endocrine 
disease, chronic hypertension or pregnancy-induced hypertension were excluded. Maternal alcohol or 
drug consumption was also an exclusion criterion. None of the women were taking nutritional 
supplements that contained specific fatty acids or lipid-soluble vitamins. A nutritional questionnaire 
was completed in order to analyze the nutritional intake [22]. This is a semi-quantitative validated 
questionnaire composed of pictures of most common Italian foods in various portions. All pregnant 
women had to indicate the frequency of each dish consumed during the month prior to sampling. Data 
were entered in software designed to calculate nutrient quantities. 
Control patients had an ultrasound scan at 30–32 wk of gestation that confirmed a normal fetal growth 
pattern, and gave birth to healthy term neonates with a birth weight between the 10th and 90th 
percentile according to Italian standards [23]. IUGR was identified as a reduction in fetal growth rate 
by ultrasound measurements of abdominal circumferences below the 10th percentile for fetuses of 
similar ages [24] or by a decrease of more than 40 percentiles from the growth curve. Growth 
restriction was confirmed at birth if the neonatal weight was below the 10th percentile [25] according to 
Italian birth weight and gestational age standards. In all cases, pregnant women were subjected to 
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elective caesarean section: in women with IUGR, a caesarean section was performed because of 
deteriorating fetal or maternal conditions, while elective caesarean took place in the control group 
because of cephalo-pelvic disproportion, repeat caesarean or breech presentation. All pregnancies 
were singleton and none of the babies showed any malformations, abnormal karyotypes or signs of 
distress at delivery. As expected, IUGR pregnancies were delivered at an average gestational age 
significantly lower than that for normal control pregnancies (appropriate gestational age, AGA). 
Therefore, in order to compare IUGR mothers with gestational age-matched controls, we included a 
second control group corresponding to nondelivered pregnant women with normal pregnancies of 
similar gestational age (AGA-35 weeks) than IUGR's; whereas IUGR fetuses were compared only with 
AGA controls. Gestational age was calculated from the last menstrual period and confirmed by an 
ultrasound examination performed at 20 weeks of gestation. 
 
Sampling 
Fasting blood samples of mothers were obtained from the maternal radial vein. Umbilical vein blood 
samples were obtained from a segment of the cord doubly clamped immediately after delivery. Both 
samples were collected in tubes containing EDTA-Na2 and kept on ice until centrifugation (1500 x g at 
4°C for 25 min). Plasma was portioned and immediately stored at -80°C until analysis. 
 
Analytic methods 
Plasma cholesterol, triacylglycerols (TG) (Spinreact Reactives, Spain) and non-esterified fatty acids 
(NEFA) (Wako Chemicals, Germany) were determined enzymatically by commercial kit. Adequate 
control plasmas with different and certified concentrations were used in all determinations to verify the 
accuracy of the assays (Accutrol, Sigma, Spain; Precinorm and Precipath, Roche Diagnostics, Spain). 
The interassay CVs were as follows: 0.9% for cholesterol; 1.3% for triacylglycerol and 1.9% for 
NEFAs. 
Plasma α-tocopherol, γ-tocopherol and retinol were measured by gradient HPLC (Beckman 
Instruments, Palo Alto, CA) after extraction with hexane, as described elsewhere [26]. Retinol acetate 
and tocopherol acetate were used as internal standards. The standard reference material SRM 968c 
from the National Institute of Standards and Technology (Gainthersburg, MD) was used as a control. 
The interassay CVs were as follows: α-tocopherol, 4.3%; γ-tocopherol, 10.6% and retinol, 3.8%. 
Plasma lipids were extracted in chloroform/methanol (2:1) [27] containing 0.005 % BHT. Fatty acids 
were transesterified with methanolic hydrochloride and analyzed on a Perkin Elmer gas 
chromatograph (Autosystem; Norwalk, CT) as previously reported [28].  
 
Statistics 
Results are expressed as means ± SEM. Statistical difference between groups was determined by 
analysis of variance (ANOVA) after adjusting for maternal BMI and gestational age; when differences 
were statistically significant, multiple comparisons were performed using Tukey's post hoc test. Paired 
Student's t-test was used to determine significant differences between maternal and umbilical plasma. 
Given their skewed distributions, concentrations of TG, NEFA and γ-tocopherol were log-transformed 
before statistical comparison. Correlations were tested with Pearson's method using the 
log-transformed data as indicated. To ascertain the independent predictors of neonate birth weight, 
stepwise multiple regression with backward selection analysis was performed. All statistical analysis 
was performed using a computer software package (Statgraphics Centurion XV, version 15.2.06, 
Statistical Graphics Corp.).  
 
 
RESULTS. 
As shown in Table 1, whereas maternal age did not differ between the groups at the beginning of 
gestation, the mean BMI was significantly higher in women who developed IUGR than in the AGA 
group matched by gestational age (AGA-35wk), although not differing with that seen in the AGA group 
studied at delivery. IUGR pregnancies were delivered on average 5 weeks earlier than normal 
pregnancies. Consequently, both the neonatal and placental weights were significantly lower in IUGR 
than in the AGA group, and whereas the ratio of placental weight to gestational age was lower in 
IUGR than in AGA, the neonate weight/placental weight did not differ between the two groups. 
The results of the nutritional questionnaire show no significant differences between the two groups in 
either the total daily caloric intake or in the total amount of proteins, carbohydrates or lipids. Also, no 
significant intergroup differences were found for any of the vitamins in the diet (vitamins A, C, D and E) 
(data not shown). 
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As shown in Table 2, plasma retinol concentration was significantly higher in pregnant women who 
developed IUGR as compared to either of the two healthy controls. Values of retinol in umbilical vein 
plasma did not differ between IUGR and AGA neonates, and they were always significantly lower than 
in maternal plasma. However, the umbilical/maternal plasma retinol ratio was much lower in the IUGR 
group than in the AGA groups (0.376±0.050 vs 0.824±0.047 respectively, p<0.0000). In maternal 
plasma, the concentration of γ-tocopherol and α-tocopherol was significantly higher in the IUGR group 
than in those with the same gestational age (AGA-35wk), although they did not differ in the IUGR and 
AGA groups.  
Cholesterol and TG levels in maternal plasma showed no differences among the groups (Table 3). 
However, NEFA levels in maternal plasma were higher in those with IUGR pregnancies than in the 
two controls. In umbilical vein plasma, concentrations of cholesterol, TG and NEFA were significantly 
lower than in maternal plasma, but values in IUGR fetuses were significantly higher than in those of 
AGA. Although there were no correlations between maternal and fetal cholesterol, the concentration of 
both TG and NEFAs in maternal plasma showed a statistically significant positive lineal correlation 
with the respective concentration of these analytes in umbilical vein plasma (r=0.4976, p=0.0002 for 
TAG and r=0.4234, p=0.0101 for NEFAs). 
 
Table 4 shows the percentage of the most relevant fatty acids. In maternal plasma, palmitic acid was 
higher and stearic acid lower in IUGR pregnancies than in AGA-35wk but similar to that in AGA. 
However, palmitoleic acid was significantly higher in plasma of women with IUGR pregnancies than 
those in either AGA-35wk or AGA, whereas oleic acid did not differ between the groups. Both the 
palmitoleic/palmitic acid and oleic/stearic acid ratios, which may be estimated as an indirect index of 
stearyl-coenzyme A desaturase (SCD) activity, were higher in maternal plasma of the IUGR group 
than in the AGA-35wk and AGA groups, although in the case of the oleic/stearic acid ratio, the 
difference between IUGR pregnancies and AGA did not reach statistical significance. In cord blood, 
the proportion of palmitic acid and palmitoleic acid did not differ from that in maternal plasma, but the 
proportion of stearic acid was higher while that of oleic acid lower. However, no differences were 
observed in any of these fatty acids in cord blood between the two groups studied. The percentage of 
linoleic acid (LA) was lower in maternal plasma of IUGR pregnancies than in either of the two control 
groups studied, whereas the percentages of long-chain polyunsaturated fatty acid products of LA (γ-
linolenic, GLA, and arachidonic acid, AA) were higher in maternal plasma of the IUGR group than in 
the controls. The GLA/LA ratio, which is an indirect estimation of ∆6-desaturase activity, was 
significantly higher in maternal plasma of IUGR pregnancies than in the control groups, indicating a 
higher conversion of LA to its product. Moreover, the overall conversion of LA into AA, calculated by 
the AA/LA ratio, was also significantly higher in women with IUGR pregnancies than in either AGA-
35wk or AGA. In umbilical vein plasma, LA values were lower and AA higher than in maternal plasma, 
also causing a higher AA/LA ratio in the former. The proportion of the different n6 fatty acids showed 
similar values in umbilical vein of IUGR and AGA neonates, except in the case of AA, whose values 
were significantly lower in umbilical vein of IUGR than in AGA. Concerning n3 fatty acids in maternal 
plasma, only the proportion of α-linolenic acid (ALA) was lower in the IUGR group than in AGA-35wk. 
In umbilical vein plasma, the proportion of eicosapentanoic (EPA) (not shown) and docosahexaenoic 
acid (DHA) was higher than in maternal plasma but no difference was found between IUGR and AGA. 
 
When we analyzed the birth weight predictors versus all the studied variables by multiple linear 
regression and backward selection, only the maternal plasma retinol and NEFAs concentrations were 
selected (Table 5).  
 
 
DISCUSSION. 
This study addresses factors that could be related to the development of IUGR pregnancies. A 
potential bias in these types of studies is related to the different gestational age at the time of 
caesarean section in IUGR compared to control pregnancies that hampers the use of appropriate 
controls. We attempted to overcome this problem by using a second group of AGA controls (AGA-
35wk), which was matched by gestational age with the IUGR pregnancies, allowing the comparison of 
maternal variables at the same gestational age. However, parameters in umbilical vein plasma of 
IUGRs, which are born premature, had to be compared with those of newborns delivered five weeks 
later. 
We have previously reported that during normal pregnancy retinol concentration in maternal plasma 
falls in the third trimester of gestation [29, 30], which may result from either its enhanced placental 
transfer or its increased uptake by the mammary gland, known to occur around parturition [31]. 
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However, we show here for the first time that plasma retinol levels in women with IUGR pregnancies 
are higher than those in pregnant controls of either the same gestational age or at term. Most cases of 
IUGR are associated with placental insufficiency, reflecting an underlying pathology resulting in an 
inability of the placenta to supply the metabolic demands of the rapidly growing fetus [32]. This finding 
agrees with previous reports showing that the IUGR placenta may be smaller and display abnormal 
vascular development [33]. We found the placental size in IUGR pregnancies was in the order of 50% 
lower than in AGA pregnant, even when corrected by gestational age. The abnormal placental 
development could be responsible for a reduced retinol transfer to the fetus, thus contributing to the 
higher levels found in maternal circulation and the lower umbilical levels. This hypothesis is supported 
by the fact that whereas the proportion of cord plasma retinol was around 65% of that found in 
maternal plasma in controls, in agreement with previous reports [34-36], it falls to 35% in IUGRs. 
Other lipophilic vitamins such as γ-tocopherol and α-tocopherol were also found here to be augmented 
in the plasma of pregnant women who developed IUGR when compared to their gestational age-
matched controls. The difference is probably not due to changes in dietary intake since food frequency 
questionnaires did not reveal differences in the daily intake between the groups. This would indicate 
that the placental transfer of these lipid moieties is also impaired in IUGR.  
The augmented ratio of monounsaturated-/saturated-fatty acids found in women with IUGR 
pregnancies indicates an enhanced SCD activity. Retinol has been shown to be an inducer of SCD 
expression [37-39], indicating its role in controlling fatty acid metabolism. Any deregulation in SCD 
expression would result in changes in the oleic acid/stearic acid ratio, as was found here in women 
with IUGR pregnancies when compared to their gestational age-matched controls. Physiologically, 
such a ratio has been reported as being an important determinant in controlling cell growth and 
differentiation through its effects on cell membrane bilayer fluidity and function [19, 40], and therefore 
its altered value in women with IUGR pregnancies could contribute in some way to this pathological 
condition.  
Other fatty acids may be implicated in the development of IUGR. As previously reported, EFA status in 
pregnant women has been related to premature delivery [41], and in agreement with previous reports 
[42, 43], a lower proportion of EFA in plasma was found in women with IUGR pregnancies than in 
controls. Since human placenta has a low activity of both delta-6 and delta-5 desaturases [44, 45], and 
the conversion of EFA to their LCPUFA derivatives in human fetus does not satisfy its necessities, 
LCPUFA in fetal circulation must be derived primarily from maternal plasma. Therefore, a deficiency of 
EFA in the mothers appears to be a contributory factor to abnormal gestational outcome development. 
In spite of this, the conversion of EFA to LCPUFAs appeared more effective in IUGR pregnancies 
because their proportion in plasma was either unchanged, as was the case for DHA, or even higher, 
as was the case of AA, compared with those found in the AGA group. Present data do not show 
decreased DHA in umbilical vein plasma of IUGR relative to AGA, as has been reported by other 
authors [46], but a reduced utilization by the fetus could compensate for its reduced transfer. The 
efficient synthesis of AA in IUGR at the maternal site, suggested by the enhanced AA/LA ratio, 
contrasts with the situation observed in cord plasma, where both AA and the AA/LA ratio were 
significantly lower in the IUGR than in the AGA group, indicating a reduced placental transfer of AA in 
the former, which could be associated with fetal growth retardation [43]. 
In the present study, we found a highly significant negative correlation between maternal retinol 
concentration and birth weight. Although we did not find precedents for the existence of such a 
correlation in a group of pregnants which included women with IUGR pregnancies, Mathews et al [47] 
in a prospective study with healthy pregnants reported that high retinol and hemoglobin concentrations 
in late pregnancy were associated with low birth weight. Together with retinol, we observed in our 
study an increase in NEFA concentration in maternal circulation that could be related to an enhanced 
lipolytic activity and/or to a decrease in placental weight and fetal development. It is hypothesized that 
both changes could be a consequence of the impaired placental function present in IUGRs, causing a 
proportional enrichment of both retinol and NEFA on the maternal side. 
 
In conclusion, the increased concentrations of retinol, NEFA and antioxidant vitamins, as well as the 
altered fatty acid profile found in the plasma of women with IUGR pregnancies, could be a 
consequence of impaired placental function. The increased circulating retinol and NEFA in women 
with IUGR pregnancies are, however, the only modified variables that appear to be directly related to 
decreased fetal development. Previous studies have demonstrated that retinol concentration decrease 
throughout normal pregnancy [29], so abnormally high retinol levels in mid-pregnancy could be a 
useful biochemical predictor marker in IUGR pregnancies. The key role of retinoids in controlling gene 
transcription involved in cell differentiation and proliferation, including SCD expression, warrants 
further research to fully understand their implication in this pathology. 
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TABLE 1. 
Maternal and neonatal characteristics of the study population 1. 
 
Characteristics. AGA-35wk IUGR AGA 
 (n=25) (n=24) (n=30) 
At initial of gestation 
   
Maternal age (y) 30.8±0.9 a 32.8±0.9 a 32.3±1.0 a 
BMI (kg/m2) 20.7±0.4 a 23.6±1.0 b 22.3±0.7 ab 
    
At delivery by caesarean 
   
BMI (kg/m2) 24.9±0.6 a 27.0±1.1 a 26.1±0.7 a 
Weeks of gestation 35.2±0.4 a 33.8±0.7 a 38.9±0.1 b 
Neonate weight (g) - 1543±114 a 3318±57 b 
Placenta weight (g) - 244±17 a 514±20 b 
Placenta weight(g)/gestational age (wk) - 7.18±0.47a 13.2±0.5b 
Neonate weight (g)/ placenta weight (g) - 6.57±0.43 a 6.64±0.20 a 
 
1
 All values are mean ± SEM. In maternal characteristics, Tukeys's test was used to determine differences among 
groups after one-way ANOVA. In neonate characteristics, Student´s t-test was used to compare values between 
IUGR and AGA groups. Different superscript letters within a row mean significant differences, P<0.05.   
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TABLE 2.  
Concentration of lipophilic vitamins (µmol/l) in maternal plasma of control pregnants at 35 weeks of pregnancy 
(AGA-35wk), and in maternal and umbilical vein plasma of IUGR and control (AGA) groups at the time of 
caesarean section 1. 
 
 MATERNAL VEIN PLASMA UMBILICAL VEIN PLASMA 
 AGA-35wk IUGR AGA IUGR AGA 
Vitamin (n=25) (n=24) (n=30) (n=24) (n=30) 
Retinol 1.00±0.070 A 1.63± 0.08 B 0.884±0.076 A 0.504±0.057 a, *** 0.748±0.052 b, *** 
γ-tocopherol 2 1.42±0.12 A 1.78±0.13 B 1.51±0.13 AB 0.451±0.056 a, *** 0.274±0.056 b, *** 
α-tocopherol 27.7±2.6 A 40.1±3.0 B 39.7±2.9 B 6.72±0.83 a, *** 6.75±0.76 a, *** 
 
1All values are mean ± SEM. Adjusted for BMI at initial of gestation and for gestational age.  
In maternal vein, Tukeys's test was used to determine differences among groups after one-way ANOVA. Different 
superscript capital letters mean significant differences between maternal values, P<0.05. In umbilical vein, 
different superscript small letters mean significant differences between umbilical values (Student's t test), P<0.01. 
Asterisk indicate differences from its respective maternal vein (Student's t test) , * P<0.05; ** P<0.01; *** P<0.001. 
2
 log-transformed skewed data for statistical comparisons. 
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TABLE 3.  
Plasma lipid concentrations (mmol/l) in maternal plasma of control pregnants at 35 weeks of pregnancy (AGA-
35wk), and in maternal and umbilical vein plasma of IUGR and control (AGA) groups at the time of caesarean 
section 1. 
 
 MATERNAL VEIN PLASMA UMBILICAL VEIN PLASMA 
 AGA-35wk IUGR AGA IUGR AGA 
Lipid (n=25) (n=24) (n=30) (n=24) (n=30) 
Cholesterol 6.31±0.29 A 6.86±0.33 A 6.39±0.32 A 1.61±0.16 a, *** 1.30±0.14 b, *** 
Triacylglycerols 2 2.34±0.23 A 2.37±0.26 A 2.15±0.25 A 0.366±0.044 a, *** 0.349±0.038 b, *** 
NEFA 2 0.329±0.042 A 0.948±0.067 B 0.599±0.050 C 0.166±0.022 a, *** 0.134±0.013 b, *** 
 
1All values are mean ± SEM. Adjusted for BMI at initial of gestation and for gestational age.  
In maternal vein, Tukeys's test was used to determine differences among groups after one-way ANOVA. Different 
superscript capital letters mean significant differences between maternal values, P<0.05. In umbilical vein, 
different superscript small letters mean significant differences between umbilical values (Student's t test), P<0.01. 
Asterisk indicate differences from its respective maternal vein (Student's t test) , * P<0.05; ** P<0.01; *** P<0.001. 
2
 log-transformed skewed data for statistical comparisons. 
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TABLE 4.  
Plasma fatty acid composition (g/100 g fatty acids) in maternal plasma of control pregnants at 35 weeks of 
pregnancy (AGA-35wk), and in maternal and umbilical vein plasma of IUGR and control (AGA) groups at the time 
of caesarean section 1. 
 
 MATERNAL VEIN PLASMA UMBILICAL VEIN PLASMA 
 AGA-35wk IUGR AGA IUGR AGA 
Fatty acid (n=25) (n=24) (n=30) (n=24) (n=30) 
C16:0  (Palmitic Acid) 24.3±0.6 A 28.9±0.7 B 27.2±0.6 B 27.8±1.3 a 25.8±1.2 a 
C18:0 (Stearic Acid) 9.74±0.51 A 6.35±0.59 B 7.11±0.57 B 15.5±2.6 a, *** 20.2±2.2 a, *** 
C16:1n-7 (Palmitoleic) 2.34±0.21 A 4.77±0.24 B 3.04±0.23 C 4.53±0.40 a 3.37±0.34 a 
C18:1n-9 (Oleic Acid) 25.3±0.6 A 26.3±0.7 A 26.5±0.7 A 18.9±0.9 a, *** 20.0±0.8 a, *** 
C16:1n-7 /C16:0 0.096±0.008 A 0.168±0.009 B 0.111±0.009 C 0.162±0.012 a 0.126±0.010 a 
C18:1n-9/C18:0 2.83±0.28 A 4.53±0.32 B 4.26±0.31 B 1.56±0.21 a, *** 1.33±0.18 a, *** 
C18:2n-6 (LA) 24.4±0.8 A 19.7±0.9 B 22.1±0.9 A 8.23±0.44 a, *** 7.72±0.38 a, *** 
C18:3n-6 (GLA) 0.080±0.028A 0.283±0.032 B 0.136±0.031 A n.d. n.d. 
C20:4n-6 (AA) 4.61±0.22 A 5.57±0.25 B 5.16±0.24 AB 10.6±0.5 a, *** 12.3±0.4 b, *** 
C18:3n-6/C18:2n-6 0.004±0.001 A 0.015±0.002 B 0.006±0.001 A - - 
C20:4n-6/C18:2n-6 0.196±0.013 A 0.289±0.016 B 0.243±0.015 A 1.33±0.10 a, *** 1.64±0.08 b, *** 
C18:3n-3 (ALA) 0.423±0.072 A 0.210±0.082 B 0.435±0.079 AB n.d. n.d. 
C22:6n-3 (DHA) 2.10±0.12 A 2.27±0.14 A 2.55±0.13 A 3.99±0.21 a, *** 3.84±0.18 a, *** 
    
Fatty acids results were expressed as a percentage (% w/w) of all detected fatty acids with a chain length in the 
range of 12-24 carbon atoms. 
1All values are mean ± SEM. Adjusted for BMI at initial of gestation and for gestational age.  
In maternal vein, Tukeys's test was used to determine differences among groups after one-way ANOVA. Different 
superscript capital letters mean significant differences between maternal values, P<0.05. In umbilical vein, 
different superscript small letters mean significant differences between umbilical values (Student's t test), P<0.01. 
Asterisk indicate differences from its respective maternal vein (Student's t test) , * P<0.05; ** P<0.01; *** P<0.001. 
n.d. non detected. 
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TABLE 5 
Multiple regression analysis of maternal contributors to birth weight. 
 
Selected predictors β P R2 
NEFA1 -514.6 0.0008 52.1 
retinol -1227.4 0.0000  
 
The model included the following independent variables: cholesterol, triacylglycerol1, NEFA1, C16:0, 
C16:1n-7, C18:0, C18:1n-9, C18:3n-3, C20:5n-3, C22:6n-3, C18:2n-6, C18:3n-6, C20:4n-6, retinol, γ-
tocopherol1 and α-tocopherol1. 
In the backward selection, variables were removed for F values lower than 4. 
Only statistically significant predictors are shown. 
1
 log transformed skewed data. 
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